Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On January 26, 2021, Omnicell, Inc. ("Omnicell" or the "Company") announced that Nhat H. Ngo will depart from his role as Executive Vice President, Marketing, Strategy & Business Development, effective February 15, 2021. The Company would like to thank Mr. Ngo for his many contributions during his Omnicell career and for being instrumental in driving Omnicell's growth and transformation from a dispensing cabinet company to today's market position as the technology-enabled solutions partner for medication management across the care continuum. Upon his departure, Mr. Ngo will be eligible for benefits under the Company's existing Amended and Restated Severance Plan, which are described in the Company's proxy statement filed with the Securities and Exchange Commission on April 7, 2020. In connection with Mr. Ngo's departure and an internal strategic reorganization, the Company has moved Mr. Ngo's marketing and strategy functions under Scott Seidelmann, the Company's Chief Commercial Officer, and the business development function under Peter Kuipers, the Company's Chief Financial Officer.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses